Fortis Life Sciences
1 known investors
Fortis Life Sciences develops and manufactures immunodetection reagents including primary and secondary antibodies, ELISA kits, antigens, engineered nanoparticles, and VHH single-domain antibody libraries. It supplies biopharma, diagnostics, research, and applied technology customers globally from North American manufacturing and R&D sites.
BiotechHealthtechMedical Devices
